[HTML][HTML] Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review

S Siddiqui, AJ Deshmukh, P Mudaliar… - Journal of the Egyptian …, 2022 - Springer
While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …

[PDF][PDF] Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review

S Siddiqui, AJ Deshmukh, P Mudaliar… - Journal of the Egyptian …, 2022 - d-nb.info
While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …

Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review.

S Siddiqui, AJ Deshmukh, P Mudaliar… - Journal of the …, 2022 - search.ebscohost.com
While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …

[PDF][PDF] Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review

S Siddiqui, AJ Deshmukh, P Mudaliar… - Journal of the …, 2022 - scienceopen.com
While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …

Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline-a review

S Siddiqui, AJ Deshmukh… - Journal of the …, 2022 - pubmed.ncbi.nlm.nih.gov
While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …

[HTML][HTML] Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review

S Siddiqui, AJ Deshmukh, P Mudaliar… - Journal of the …, 2022 - ncbi.nlm.nih.gov
While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …

[PDF][PDF] Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review

S Siddiqui, AJ Deshmukh, P Mudaliar… - Journal of the Egyptian …, 2022 - academia.edu
While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …

[HTML][HTML] Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review

S Siddiqui, AJ Deshmukh, P Mudaliar… - Journal of the …, 2022 - jenci.springeropen.com
While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …

Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline-a review.

S Siddiqui, AJ Deshmukh, P Mudaliar… - Journal of the …, 2022 - europepmc.org
While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …

[PDF][PDF] Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review

S Siddiqui, AJ Deshmukh, P Mudaliar… - Journal of the …, 2022 - jenci.springeropen.com
While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …